Severe Infantile Bullous Pemphigoid Treated with Dapsone after Bridging with Systemic Glucocorticoid
We present a case of severe and treatment-refractory bullous pemphigoid in a 3-month-old child. After topical and systemic corticoid treatment proved inefficient, dapsone 0.75 mg/kg was added initially without success. Disease control was reached with dapsone 1.5 mg/kg in addition to both topical an...
Main Authors: | Kenneth Thomsen, Mette Deleuran, Christian Vestergaard, Mette Holm, Rikke Riber-Hansen, Rikke Bech |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-06-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/501359 |
Similar Items
-
Dapsone – mechanism of action, safety of use and the role in the treatment of bullous pemphigoid according to current recommendations
by: Magdalena Żychowska, et al.
Published: (2016-05-01) -
Anti-p200 pemphigoid responding to dapsone
by: Laura Van Lerberghe, et al.
Published: (2014-03-01) -
Bullous pemphigoid: Management during COVID-19 pandemic
by: Ajit B Janagond, et al.
Published: (2021-01-01) -
Bullous eczema presenting as bullous pemphigoid-like eruption: A case series
by: George Atteh, BS, et al.
Published: (2021-04-01) -
Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature
by: Rikke Bech, et al.
Published: (2018-09-01)